MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.

MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.

No trades
See on Supercharts
Market capitalization
‪2.37 B‬SAR
‪65.83 M‬SAR
‪338.44 M‬SAR
‪6.66 M‬
Beta (1Y)
1.07
Employees (FY)
543
Change (1Y)
+10 +1.88%
Revenue / Employee (1Y)
‪623.28 K‬SAR
Net income / Employee (1Y)
‪121.23 K‬SAR

About MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO.


CEO
Mohammed Maher Mohammed Lotfi Al-Ghannam
Headquarters
Riyadh
Founded
1998
ISIN
SA160G51UO10
FIGI
BBG01L820FZ7
Middle East Pharmaceutical Industries Co. engages in the development, manufacture, marketing, and distribution of a wide range of generic medicines and pharmaceuticals. It operates through the following segments: Public, Private, and Export. The company was founded by Ahmad Shaher Ahmad Al-Tabbaa in 1998 and is headquartered in Riyadh, Saudi Arabia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4016 is 117.0 SAR — it has decreased by −1.33% in the past 24 hours. Watch MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. stocks are traded under the ticker 4016.
4016 stock has fallen by −2.47% compared to the previous week, the month change is a −3.10% fall, over the last year MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. has showed a 29.71% increase.
4016 reached its all-time high on Mar 3, 2024 with the price of 197.6 SAR, and its all-time low was 90.2 SAR and was reached on Feb 27, 2024. View more price dynamics on 4016 chart.
See other stocks reaching their highest and lowest prices.
4016 stock is 3.25% volatile and has beta coefficient of 1.07. Track MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. stock price on the chart and check out the list of the most volatile stocks — is MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. there?
Yes, you can track MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. financials in yearly and quarterly reports right on TradingView.
4016 net income for the last quarter is ‪3.87 M‬ SAR, while the quarter before that showed ‪21.81 M‬ SAR of net income which accounts for −82.27% change. Track more MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. financial stats to get the full picture.
As of Dec 22, 2024, the company has 543.00 employees. See our rating of the largest employees — is MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. on this list?
Like other stocks, 4016 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. stock shows the strong sell signal. See more of MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.